Literature DB >> 11205107

Immune responses and cytokine induction in the development of severe hepatitis during acute infections with murine cytomegalovirus.

J Trgovcich1, D Stimac, B Polić, A Krmpotić, E Pernjak-Pugel, J Tomac, M Hasan, B Wraber, S Jonjić.   

Abstract

Salivary gland-derived murine cytomegalovirus (SGV) infections of mice have been widely used as models of human cytomegalovirus infections and in the study of CMV biology. Still, many aspects of SGV pathogenesis are not clearly defined. Fatal and non-fatal SGV infections were investigated to characterize pathogenetic correlates of mortality and to assess the role of the immune response in disease progression. Suppression of immune responses was observed in both lethal and sublethal infections. Depletion of immune cell populations in spleen, however, correlated with severe CMV-induced hepatitis and mortality. In addition, T cell depletion studies indicated a requirement for this immune cell subset in control of liver damage and survival of infected mice. Examination of cytokine responses revealed a previously undescribed shock-like syndrome in lethally-infected mice characterized by high levels of tumor necrosis factor alpha and interferon gamma. Furthermore, the sites of tumor necrosis factor alpha gene induction did not strictly correlate with either viral load or the sites of tissue damage during infection. Taken together, these findings define the pathogenetic progression of disease as it relates to disease outcome and suggests that organ-specific differences in cytokine induction play a significant role in the late stages of acute lethal MCMV infections.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11205107     DOI: 10.1007/s007050070010

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  31 in total

1.  Recombinant mouse cytomegalovirus expressing a ligand for the NKG2D receptor is attenuated and has improved vaccine properties.

Authors:  Irena Slavuljica; Andreas Busche; Marina Babić; Maja Mitrović; Iva Gašparović; Durđica Cekinović; Elitza Markova Car; Ester Pernjak Pugel; Ana Ciković; Vanda Juranić Lisnić; William J Britt; Ulrich Koszinowski; Martin Messerle; Astrid Krmpotić; Stipan Jonjić
Journal:  J Clin Invest       Date:  2010-11-22       Impact factor: 14.808

2.  Murine Cytomegalovirus Glycoprotein O Promotes Epithelial Cell Infection In Vivo.

Authors:  Joseph Yunis; Helen E Farrell; Kimberley Bruce; Clara Lawler; Orry Wyer; Nicholas Davis-Poynter; Ilija Brizić; Stipan Jonjić; Barbara Adler; Philip G Stevenson
Journal:  J Virol       Date:  2019-01-17       Impact factor: 5.103

3.  The Canonical Immediate Early 3 Gene Product pIE611 of Mouse Cytomegalovirus Is Dispensable for Viral Replication but Mediates Transcriptional and Posttranscriptional Regulation of Viral Gene Products.

Authors:  Stephanie Rattay; Mirko Trilling; Dominik A Megger; Barbara Sitek; Helmut E Meyer; Hartmut Hengel; Vu Thuy Khanh Le-Trilling
Journal:  J Virol       Date:  2015-06-10       Impact factor: 5.103

4.  Alveolar Macrophages Are a Prominent but Nonessential Target for Murine Cytomegalovirus Infecting the Lungs.

Authors:  Helen E Farrell; Clara Lawler; Martha T Oliveira; Nick Davis-Poynter; Philip G Stevenson
Journal:  J Virol       Date:  2015-12-30       Impact factor: 5.103

Review 5.  Immunobiology of congenital cytomegalovirus infection of the central nervous system—the murine cytomegalovirus model.

Authors:  Irena Slavuljica; Daria Kveštak; Peter Csaba Huszthy; Kate Kosmac; William J Britt; Stipan Jonjić
Journal:  Cell Mol Immunol       Date:  2014-07-21       Impact factor: 11.530

6.  A spread-deficient cytomegalovirus for assessment of first-target cells in vaccination.

Authors:  Christian Andreas Mohr; Jurica Arapovic; Hermine Mühlbach; Marc Panzer; Annelies Weyn; Lars Dölken; Astrid Krmpotic; David Voehringer; Zsolt Ruzsics; Ulrich Koszinowski; Torsten Sacher
Journal:  J Virol       Date:  2010-05-12       Impact factor: 5.103

7.  Systemic immune deficiency necessary for cytomegalovirus invasion of the mature brain.

Authors:  Jon D Reuter; Daniel L Gomez; Jean H Wilson; Anthony N Van Den Pol
Journal:  J Virol       Date:  2004-02       Impact factor: 5.103

8.  Passive immunization reduces murine cytomegalovirus-induced brain pathology in newborn mice.

Authors:  Durdica Cekinović; Mijo Golemac; Ester Pernjak Pugel; Jelena Tomac; Luka Cicin-Sain; Irena Slavuljica; Russell Bradford; Sonja Misch; Thomas H Winkler; Michael Mach; William J Britt; Stipan Jonjić
Journal:  J Virol       Date:  2008-10-08       Impact factor: 5.103

9.  The M33 G protein-coupled receptor encoded by murine cytomegalovirus is dispensable for hematogenous dissemination but is required for growth within the salivary gland.

Authors:  Fabiola M Bittencourt; Shu-En Wu; James P Bridges; William E Miller
Journal:  J Virol       Date:  2014-08-06       Impact factor: 5.103

10.  A cytomegalovirus inhibitor of gamma interferon signaling controls immunoproteasome induction.

Authors:  Selina Khan; Albert Zimmermann; Michael Basler; Marcus Groettrup; Hartmut Hengel
Journal:  J Virol       Date:  2004-02       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.